1. Home
  2. Labeler Index
  3. The Wellness Center For Research And Education, Inc.
  4. NDC Product Code: 50181-0062 Biotox VI

NDC 50181-0062 Biotox VI

Cochlearia Armoracia,Spleen (bovine),Thymus Gland (bovine),Influenzinum - View Dosage, Usage, Ingredients, Routes, UNII

Table of Contents

  1. Product Information
  2. Product Packages
  3. What is NDC 50181-0062?
  4. Biotox VI Uses
  5. Active Ingredients
  6. Active Ingredients UNII Codes
  7. Inactive Ingredients UNII Codes
  8. Pharmacologic Classes

Product Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.

Get all the details for National Drug Code (NDC) 50181-0062 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive substances, package configurations, billing units, labeler information, and routes of administration. It also includes enhanced data such as HCPCS codes, FDA product labels with images, UNIIs, and RxNorm cross-references. Whether you're a healthcare professional verifying drug data or a consumer researching medication, this NDC page helps you make informed, accurate decisions.

NDC Product Code:
50181-0062
Proprietary Name:
Biotox VI
Non-Proprietary Name: [1]
Cochlearia Armoracia, Spleen (bovine), Thymus Gland (bovine), Influenzinum (2019-2020), Mycoplasma Pneumoniae, Cytomegalovirus Nosode, Human Papilloma Nosode, Coxsackie B1 Nosode, Coxsackie B4 Nosode, Pneumococcinum, Carcinosin
Substance Name: [2]
Bos Taurus Spleen; Bos Taurus Thymus; Horseradish; Human Breast Tumor Cell; Human Coxsackievirus B1; Human Coxsackievirus B4; Human Herpesvirus 5; Human Papillomavirus; Influenza A Virus A/brisbane/02/2018 Ivr-190 (h1n1) Antigen (formaldehyde Inactivated); Influenza A Virus A/kansas/14/2017 X-327 (h3n2) Antigen (formaldehyde Inactivated); Influenza B Virus B/maryland/15/2016 Antigen (formaldehyde Inactivated); Mycoplasma Pneumoniae; Streptococcus Pneumoniae
NDC Directory Status:
Human Prescription Drug
Product Type: [3]
ACTIVE PRODUCT INCLUDED in the NDC Directory
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route(s): [4]
Oral - Administration to or by way of the mouth.
Labeler Name: [5]
The Wellness Center For Research And Education, Inc.
Labeler Code:
50181
Product Label ID:
5bc05369-ad93-4e91-88bc-aaa6fc7c35ca
Marketing Category: [8]
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date: [9]
03-09-2020
End Marketing Date: [10]
10-04-2025
Exclude Flag: [12]
N
Code Navigator:

Code Structure Chart

Product Details

What is NDC 50181-0062?

The NDC code 50181-0062 is assigned by the FDA to the product Biotox VI which is a human prescription drug product labeled by The Wellness Center For Research And Education, Inc.. The generic name of Biotox VI is cochlearia armoracia, spleen (bovine), thymus gland (bovine), influenzinum (2019-2020), mycoplasma pneumoniae, cytomegalovirus nosode, human papilloma nosode, coxsackie b1 nosode, coxsackie b4 nosode, pneumococcinum, carcinosin. The product's dosage form is liquid and is administered via oral form. The product is distributed in a single package with assigned NDC code 50181-0062-1 30 ml in 1 bottle, dropper . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Biotox VI?

Fatigue, fever, cough, flu-like symptoms, heart palpitations, virus, pain, swelling and stiffness of limbs. Fatigue, fever, cough, flu-like symptoms, heart palpitations, virus, pain, swelling and stiffness of limbs.

What are Biotox VI Active Ingredients?

An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Which are Biotox VI UNII Codes?

The UNII codes for the active ingredients in this product are:

  • HORSERADISH (UNII: 8DS6G120HJ)
  • HORSERADISH (UNII: 8DS6G120HJ) (Active Moiety)
  • BOS TAURUS SPLEEN (UNII: 190Q9MB3U3)
  • BOS TAURUS SPLEEN (UNII: 190Q9MB3U3) (Active Moiety)
  • BOS TAURUS THYMUS (UNII: 8XEJ88V2T8)
  • BOS TAURUS THYMUS (UNII: 8XEJ88V2T8) (Active Moiety)
  • INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: XW4JB03TI5)
  • INFLUENZA A VIRUS A/BRISBANE/02/2018 IVR-190 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: 92XE6GHC89) (Active Moiety)
  • INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: 3NZW5ND3D6)
  • INFLUENZA A VIRUS A/KANSAS/14/2017 X-327 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: K329YCD1N9) (Active Moiety)
  • INFLUENZA B VIRUS B/MARYLAND/15/2016 ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: 8V4458342X)
  • INFLUENZA B VIRUS B/MARYLAND/15/2016 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: OES3CXI7E9) (Active Moiety)
  • MYCOPLASMA PNEUMONIAE (UNII: JQE470FAD0)
  • MYCOPLASMA PNEUMONIAE (UNII: JQE470FAD0) (Active Moiety)
  • HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K)
  • HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K) (Active Moiety)
  • HUMAN PAPILLOMAVIRUS (UNII: 23CVL7WF4J)
  • HUMAN PAPILLOMAVIRUS (UNII: 23CVL7WF4J) (Active Moiety)
  • HUMAN COXSACKIEVIRUS B1 (UNII: ADL68M27WD)
  • HUMAN COXSACKIEVIRUS B1 (UNII: ADL68M27WD) (Active Moiety)
  • HUMAN COXSACKIEVIRUS B4 (UNII: FYF75V7FDY)
  • HUMAN COXSACKIEVIRUS B4 (UNII: FYF75V7FDY) (Active Moiety)
  • STREPTOCOCCUS PNEUMONIAE (UNII: BT6U234YR2)
  • STREPTOCOCCUS PNEUMONIAE (UNII: BT6U234YR2) (Active Moiety)
  • HUMAN BREAST TUMOR CELL (UNII: C62OO7VD9K)
  • HUMAN BREAST TUMOR CELL (UNII: C62OO7VD9K) (Active Moiety)

Which are Biotox VI Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

Which are the Pharmacologic Classes for Biotox VI?

* Please review the disclaimer below.

Product Footnotes

[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.

[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[10] What is the End Marketing Date? - This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".